While psychedelics are still illegal under U.S. federal law, companies are jostling to try and patent key ingredients found in magic mushrooms, ayahuasca and other substances.
Recent events, such as the service fee cuts in Alberta, underscore the volatility of government funding and highlight the need for pharmacies to diversify their revenue streams.